|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||||
|
||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s8EA1368C-5AD5-11EF-8CBD-13FE84CE164B&I=39IZM&T=&OP=Display&O=html&O1=15194185&O2=954925551352&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DUtility%2520of%2520Assessing%2520the%2520Number%2520of%2520Mutated%2520KRAS%252C%2520CDKN2A%252C%2520TP53%252C%2520and%2520SMAD4%2520Genes%2520Using%2520a%2520Targeted%2520Deep%2520Sequencing%2520Assay%2520as%2520a%2520Prognostic%2520Biomarker%2520for%2520Pancreatic%2520Cancer%26rft.au%3DHayashi%252C%2520Hideyuki%26rft.au%3DHiraoka%252C%2520Nobuyoshi%26rft.au%3DKohno%252C%2520Takashi%26rft.au%3DUeno%252C%2520Hideki%26rft.date%3D2017-03-01%26rft.eissn%3D1536-4828%26rft.externalDocID%3D28099251%26rft.genre%3Darticle%26rft.issue%3D3%26rft.jtitle%3DPancreas%26rft.spage%3D335%26rft.volume%3D46%26rft_id%3Dinfo%253Adoi%252F10.1097%252Fmpa.0000000000000760%26rft_id%3Dinfo%253Apmid%252F28099251%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-JOURNALS_AT_OVID_LWW_PROPRIETARY_COLLECTION_EMERGING_MARKET-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-ISI_WEB_OF_SCIENCE-getAuthor-object,6-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,7-REFWORKS_EXPORT_TOOL-getReference-object,8-NCBI_PUBMED_FREE-getCitedRecord-object,9-SHERPA_RoMEO_LCL-getWebService-object,10-GOOGLE_SCHOLAR_FREE-getWebSearch-object,11-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.725354&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15194185-s8EA1368C-5AD5-11EF-8CBD-13FE84CE164B" timestamp="2024-08-15T09:11:44Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925551352</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer</jnl:atitle>
<jnl:jtitle>Pancreas</jnl:jtitle>
<jnl:date>2017-03-00</jnl:date>
<jnl:spage>335</jnl:spage>
<jnl:epage>340</jnl:epage>
<jnl:coden>PANCE4</jnl:coden>
<jnl:issn>0885-3177</jnl:issn>
<jnl:volume>46</jnl:volume>
<jnl:issue>3</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1536-4828</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>PANCE4</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:e60a6b6167df470680d60f8017e032eabb991d53</ctx:identifier>
<ctx:identifier>urn:UUID:s8EA1368C-5AD5-11EF-8CBD-13FE84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)